Suppr超能文献

中药注射剂引起过敏反应的体外实验

In vitro experiment of allergic reactions induced by traditional Chinese medicine injections.

作者信息

Kang Rui-xia, You Rong-li, Wang Lei, Lei Lei, Wang Zhong

出版信息

Zhongguo Zhong Yao Za Zhi. 2015 Jul;40(13):2503-7.

Abstract

Allergic reactions caused by traditional Chinese medicine injections (TCMIs) become a greatest concern in the clinic application safety. The integral animal evaluation method commonly used in the preclinical evaluation for allergic reactions of TCMIs was not sensitive, specific, quick and objective in observation indexes. Therefore, more researchers have paid attention to the in vitro test method for evaluating allergic reactions induced by TCMIs. Currently, the methods for evaluating allergic reactions induced by TCMIs are mainly targeted at type I allergic reaction and anaphylactic reaction, with only a few in vitro methods for evaluating type II allergic reaction. In this paper, researchers summarized relevant literatures published about evaluation methods for allergic reactions induced by TCMIs in recent years.

摘要

中药注射剂(TCMIs)引起的过敏反应成为临床应用安全性中最受关注的问题。目前中药注射剂过敏反应临床前评价常用的整体动物评价方法在观察指标上不敏感、不特异、不快速且不客观。因此,越来越多的研究者关注中药注射剂过敏反应的体外评价方法。目前,中药注射剂过敏反应的评价方法主要针对Ⅰ型过敏反应和过敏性反应,而评价Ⅱ型过敏反应的体外方法较少。本文中,研究者总结了近年来发表的有关中药注射剂过敏反应评价方法的相关文献。

相似文献

6
Pseudo-allergic reactions induced by Chinese medicine injections: a review.
Chin Med. 2023 Nov 13;18(1):149. doi: 10.1186/s13020-023-00855-0.
7
Advances in analytical techniques and quality control of traditional Chinese medicine injections.
J Pharm Biomed Anal. 2021 Nov 30;206:114353. doi: 10.1016/j.jpba.2021.114353. Epub 2021 Sep 1.
8
[Research progress of 5-hydroxymethylfurfural, a safety-related substance in traditional Chinese medicine injections].
Zhongguo Zhong Yao Za Zhi. 2017 May;42(10):1842-1846. doi: 10.19540/j.cnki.cjcmm.2017.0074.
10
[Analysis and considerations on revision of instructions for traditional Chinese medicine injections].
Zhongguo Zhong Yao Za Zhi. 2021 Apr;46(7):1839-1845. doi: 10.19540/j.cnki.cjcmm.20200708.501.

引用本文的文献

1
Astragaloside IV Inhibits the Progression of Non-Small Cell Lung Cancer Through the Akt/GSK-3β/β-Catenin Pathway.
Oncol Res. 2019 Mar 29;27(4):503-508. doi: 10.3727/096504018X15344989701565. Epub 2018 Aug 21.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验